These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36894745)

  • 1. Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin.
    Kim HY; Otgontenger U; Kim JW; Lee YJ; Kim SB; Lim SC; Kim YM; Kang KW
    Arch Pharm Res; 2023 Mar; 46(3):149-159. PubMed ID: 36894745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome.
    Kim HY; Choi YJ; Kim SK; Kim H; Jun DW; Yoon K; Kim N; Hwang J; Kim YM; Lim SC; Kang KW
    Commun Biol; 2021 Jun; 4(1):824. PubMed ID: 34193972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-β/NLRP3 inflammasome pathway.
    Lin L; Zhou M; Que R; Chen Y; Liu X; Zhang K; Shi Z; Li Y
    Biochem Cell Biol; 2021 Oct; 99(5):666-674. PubMed ID: 33974808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways.
    Zaghloul RA; Zaghloul AM; El-Kashef DH
    Life Sci; 2022 Apr; 295():120410. PubMed ID: 35182557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.
    Inzaugarat ME; Johnson CD; Holtmann TM; McGeough MD; Trautwein C; Papouchado BG; Schwabe R; Hoffman HM; Wree A; Feldstein AE
    Hepatology; 2019 Feb; 69(2):845-859. PubMed ID: 30180270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome.
    Niu WX; Bao YY; Zhang N; Lu ZN; Ge MX; Li YM; Li Y; Chen MH; He HW
    Bioorg Chem; 2022 Oct; 127():105971. PubMed ID: 35749855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-κB.
    Zhang WJ; Fang ZM; Liu WQ
    Parasit Vectors; 2019 Jan; 12(1):29. PubMed ID: 30635040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney.
    Ke Q; Shi C; Lv Y; Wang L; Luo J; Jiang L; Yang J; Zhou Y
    FASEB J; 2022 Jan; 36(1):e22078. PubMed ID: 34918381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes.
    Rudkowski R; Graham GG; Champion GD; Ziegler JB
    Biochem Pharmacol; 1990 Jun; 39(11):1687-95. PubMed ID: 2160817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway.
    Liu J; Fan G; Tao N; Feng F; Meng C; Sun T
    Drug Des Devel Ther; 2022; 16():1793-1809. PubMed ID: 35719213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway.
    Bao X; Li J; Ren C; Wei J; Lu X; Wang X; Du W; Jin X; Ma B; Zhang Q; Ma B
    Chem Biol Interact; 2022 Sep; 365():110074. PubMed ID: 35961541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin.
    Isakov E; Weisman-Shomer P; Benhar M
    Biochim Biophys Acta; 2014 Oct; 1840(10):3153-61. PubMed ID: 25065288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of hepatic fibrosis by p-Coumaric acid via modulation of NLRP3 inflammasome activation in C57BL/6 mice.
    Truong TMT; Seo SH; Chung S; Kang I
    J Nutr Biochem; 2023 Feb; 112():109204. PubMed ID: 36400112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on role of traditional Chinese medicine in hepatic fibrosis based on miRNA-mediated activation of NLRP3 inflammasome].
    Guo XH; Zheng Y; Wang JH; Wang HH; Luo SJ; Huang N; Zhao TJ; Zheng BW; Liang XY; Wu RZ; Ren QY
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2409-2418. PubMed ID: 35531688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.
    Cai SM; Yang RQ; Li Y; Ning ZW; Zhang LL; Zhou GS; Luo W; Li DH; Chen Y; Pan MX; Li X
    Antioxid Redox Signal; 2016 May; 24(14):795-812. PubMed ID: 26728324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy Attenuates Angiotensin II-Induced Pulmonary Fibrosis by Inhibiting Redox Imbalance-Mediated NOD-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation.
    Meng Y; Pan M; Zheng B; Chen Y; Li W; Yang Q; Zheng Z; Sun N; Zhang Y; Li X
    Antioxid Redox Signal; 2019 Feb; 30(4):520-541. PubMed ID: 29486589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Absence of NLRP3-inflammasome Modulates Hepatic Fibrosis Progression, Lipid Metabolism, and Inflammation in KO NLRP3 Mice during Aging.
    Gallego P; Castejón-Vega B; Del Campo JA; Cordero MD
    Cells; 2020 Sep; 9(10):. PubMed ID: 32977490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome.
    Hou L; Yang L; Chang N; Zhao X; Zhou X; Dong C; Liu F; Yang L; Li L
    Front Immunol; 2020; 11():1149. PubMed ID: 32695095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro.
    Hwangbo H; Kim MY; Ji SY; Kim SY; Lee H; Kim GY; Park C; Keum YS; Hong SH; Cheong J; Choi YH
    Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
    Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
    Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.